Skip to main content

Table 2 Baseline characteristics of the study patients

From: Intake of partially defatted Brazil nut flour reduces serum cholesterol in hypercholesterolemic patients- a randomized controlled trial

Characteristics

Brazil nut (n = 35)

Placebo (n = 42)

Age – years

59.6 ± 10.8

60.4 ± 9.9

Elderly – n (%)*

19 (54.3 %)

22 (52.4 %)

Male – n (%)

20 (57.1 %)

23 (54.8 %)

Diabetes – n (%)

17 (48.6 %)

15 (35.7 %)

BMI– kg/m2

29.9 ± 6.5

29.3 ± 4.8

Overweight / obesity – n. (%)

27 (77.1 %)

35 (83.3 %)

Plasma selenium - μg/L

88.7 ± 15.3

86.6 ± 17.2

Physical activity – n (%)†

13 (37.1 %)

14 (33.3 %)

MET (kcal/day)

23.8 ± 46.1

27.1 ± 53.8

Drug therapy – n (%)

  

Lipid-lowering drugs

  

 Statins

31 (88.6)

35 (83.3)

 Ezetimibe

18 (51.4)

15 (35.7)

 Fibrate

15 (42.8)

14 (33.3)

Antihypertensive drugs

  

 Diuretics

25 (71.4)

26 (61.9)

 ACE Inhibitors

16 (45.7)

22 (52.4)

 Calcium channel blockers

14 (40.0)

15 (35.7)

 Sympatholytic

31 (88.6)

35 (83.3)

 Vasodilators

16 (45.7)

20 (47.6)

 ARB

13 (37.1)

14 (33.3)

  1. Mean ± SD or n (%). BMI Body mass index; MET metabolic equivalent; ACE angiotensin-converting enzyme; ARB angiotensin II receptor blockers
  2. * Individuals older than 60
  3. † Expressed as the percentage of individuals who responded positively to these questions (% Yes)
  4. For quantitative variables, we used a Student’s t test for independent samples (selenium and age) or a Mann–Whitney U test for variables with normal and non-normal distributions, respectively. For categorical variables, we used a chi-squared test. There was no significant difference between groups at baseline